Latest news
aTyr lays off 60% of workforce to fund 2nd attempt at phase 3 success for lung disease drug - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 08:27:53 GMTLevi & Korsinsky Urges aTyr (ATYR) Shareholders to Act Before Lead Plaintiff Deadline December 8, 2025 - The National Law ReviewThe National Law Review · Mon, 10 Aug 2026 01:09:17 GMTATYR Jan 2028 1.000 call (ATYR280121C00001000) interactive stock chart - Yahoo Finance UKYahoo Finance UK · Sun, 09 Aug 2026 02:47:06 GMTATyr Pharma Shrinks Losses And Plans Deep Cost Cuts - FinimizeFinimize · Sat, 08 Aug 2026 17:18:00 GMTATYR Nov 2026 1.000 put (ATYR261120P00001000) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Sat, 08 Aug 2026 12:50:52 GMTATyr Pharma Announces Second Quarter 2026 Res - MoomooMoomoo · Sat, 08 Aug 2026 11:25:02 GMTATYR Looks 13.6% Overvalued on GF Value™ as Cash Supports Develo - GuruFocusGuruFocus · Sat, 08 Aug 2026 00:54:14 GMTATYR Looks 13.6% Overvalued on GF Value™ as It Restructures Amid Pulmonary Sarcoidosis Focus - GuruFocusGuruFocus · Fri, 07 Aug 2026 23:18:54 GMT